<?xml version="1.0" encoding="UTF-8"?>
<p>The patient was treated with Lianhua Qingwen capsules 16.8 g three times daily, umifenovir 200 mg three times daily, and lopinavir and ritonavir tablets 600 mg twice daily for 2 days. She was transferred to Ningbo No. 2 Hospital on 30 January. She was then treated with moxifloxacin, umifenovir, lopinavir, and ritonavir tablets, interferon-2α, and thymosin. After several days of symptomatic treatment, cough and suffocation in the chest gradually subsided. A chest CT scan showed major improvement. RT-PCR for SARS-CoV-2 was negative twice from throat swab specimens on 5 and 6 February 2020 and once with a rectal swab specimen on 6 February 2020. In accordance with the guidelines, the patient was clear of SARS-CoV-2 and was discharged from the hospital on 6 February 2020.
 <sup>
  <xref rid="bibr7-0300060520952256" ref-type="bibr">7</xref>
 </sup>
</p>
